(Q42263085)

English

Overall safety profile of boceprevir plus peginterferon alfa-2b and ribavirin in patients with chronic hepatitis C genotype 1: a combined analysis of 3 phase 2/3 clinical trials

scientific article published on 9 October 2013

Statements

Overall safety profile of boceprevir plus peginterferon alfa-2b and ribavirin in patients with chronic hepatitis C genotype 1: a combined analysis of 3 phase 2/3 clinical trials (English)
Mitchel L Shiffman
Jean-Pierre Bronowicki
Franco Felizarta
Margaret Burroughs
Clifford A Brass
Janice K Albrecht

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit